Wordt geladen...
Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing
Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...
Bewaard in:
| Gepubliceerd in: | Mol Med Rep |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/ https://ncbi.nlm.nih.gov/pubmed/26059981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|